Problems associated with in vitro assessment of drug inhibition of CYP3A4 and other P-450 enzymes and its impact on drug discovery.
about
Polymorphic cytochrome P450 2D6: humanized mouse model and endogenous substrates.Multiple doses of the antimuscarinic agent solifenacin do not affect the pharmacodynamics or pharmacokinetics of warfarin or the steady-state pharmacokinetics of digoxin in healthy subjects.Pharmacokinetic effect of ketoconazole on solifenacin in healthy volunteers.In vitro tests for predicting drug-drug interactions: the need for validated procedures.Cytochrome P450 reaction-phenotyping: an industrial perspective.Streptomyces cytochromes P450: applications in drug metabolism.
P2860
Problems associated with in vitro assessment of drug inhibition of CYP3A4 and other P-450 enzymes and its impact on drug discovery.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Problems associated with in vi ...... its impact on drug discovery.
@ast
Problems associated with in vi ...... its impact on drug discovery.
@en
Problems associated with in vi ...... its impact on drug discovery.
@nl
type
label
Problems associated with in vi ...... its impact on drug discovery.
@ast
Problems associated with in vi ...... its impact on drug discovery.
@en
Problems associated with in vi ...... its impact on drug discovery.
@nl
prefLabel
Problems associated with in vi ...... its impact on drug discovery.
@ast
Problems associated with in vi ...... its impact on drug discovery.
@en
Problems associated with in vi ...... its impact on drug discovery.
@nl
P1476
Problems associated with in vi ...... its impact on drug discovery.
@en
P2093
Wienkers LC
P356
10.1016/S1056-8719(01)00121-6
P577
2001-01-01T00:00:00Z